SCHEMBL22340957

SCHEMBL22340957

CCCC(C)N(Cc1ccc(OC)cc1)Cc1ccco1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
POLB P06746 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TAS2R14 Q9NYV8 1/20 0.45
ALDH1A1 P00352 5/20 0.44
LMNA P02545 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 1/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HTT P42858 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 2/20 0.43
TSHR P16473 3/20 0.43
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20871414 0.90 MAPT (0.57) MAPTCNR1CNR2POLBMEN1
SCHEMBL29335450 0.85 MAPT (0.57) MAPTCNR1CNR2POLBMEN1
SCHEMBL22340945 0.78 BCHE (0.56) MAPTPOLBTAS2R14LMNAL3MBTL1
SCHEMBL29336128 0.76 MAPT (0.56) MAPTCNR1CNR2POLBTAS2R14
SCHEMBL29335338 0.76 MAPT (0.50) MAPTCNR1CNR2POLBMEN1
SCHEMBL22340462 0.76 MAPT (0.58) MAPTCNR1CNR2POLBTAS2R14
SCHEMBL22340935 0.75 MAPT (0.52) MAPTCNR1CNR2POLBMEN1
SCHEMBL22340949 0.74 BCHE (0.62) MEN1KMT2ATAS2R14ALDH1A1LMNA
SCHEMBL20871033 0.74 MAPT (0.54) MAPTCNR1CNR2POLBTAS2R14
SCHEMBL20871191 0.74 SMN1; SMN2 (0.45) POLBALDH1A1L3MBTL1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707132-B1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES UNIV PARIS SACLAY (FR) 2024-07-17 EP disclosed
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 MAPT 2186/4885CNR1 1297/4885CNR2 1633/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A MAPT 1922/4885CNR1 1767/4885CNR2 2182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.